Krka Keeps Up Strong Performance Despite Rouble Risks
The Company Remains Russia’s Largest Foreign Generics Provider
Krka has maintained strong growth in the past nine months despite ongoing questions surrounding its significant presence in Russia and foreign currency risks linked to the rouble.
